Ocean Biomediacal, Inc. Warrants
OCEAW
OCEAW was delisted on the 23rd of April, 2025.
15 hedge funds and large institutions have $155K invested in Ocean Biomediacal, Inc. Warrants in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 15 → 15 (0)
47% less capital invested
Capital invested by funds: $294K → $155K (-$139K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Trading
New York
|
+$6.15K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$27 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$7.44K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$2.98K |
| 3 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$133 |
| 4 |
CS
Clear Street
New York
|
-$4 |
OCEAW Hedge Fund Activity: Q4 2024 in Review
15 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomediacal, Inc. Warrants (OCEAW) for Q4 2024, worth a combined $155K — down 47% from $294K a quarter earlier.
Fund positioning in OCEAW was balanced in Q4 2024: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 4 trimmed.
The largest buyer was Walleye Trading, adding an estimated $6.15K. The largest seller was Walleye Capital, cutting an estimated $7.44K.
- 15 institutional investors held Ocean Biomediacal, Inc. Warrants (OCEAW) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $155K of Ocean Biomediacal, Inc. Warrants stock for Q4 2024, down 47% quarter-over-quarter.
- 0 funds opened new Ocean Biomediacal, Inc. Warrants positions in Q4 2024 and 0 closed out.
- The largest Ocean Biomediacal, Inc. Warrants buyer in Q4 2024 was Walleye Trading, an estimated $6.15K added.
- The largest Ocean Biomediacal, Inc. Warrants seller in Q4 2024 was Walleye Capital, an estimated $7.44K sold.
Based on aggregated 13F filings for Q4 2024.